Masayoshi Harigai

14.5k citations

345 papers · 8.1k indexed · 1 hit paper · h-index 46

Rheumatology top 0.1%
- Rheumatoid Arthritis Research and Therapies 138
- Systemic Lupus Erythematosus Research 88
Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research 40
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 70
Immunology top 1%
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment 45
- Systemic Sclerosis and Related Diseases 23
Pulmonary and Respiratory Medicine
- Vasculitis and related conditions 60
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 27

Co-authors: John C. Reed Hisashi Yamanaka Masahito Hanada Masako Hara Tsutomu Takeuchi Toshiyuki Miyashita Yoshiya Tanaka Nobuyuki Miyasaka
Cited by: Rheumatology Hematology Genetics
Journals: Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)The Journal of Immunology (2 papers)
Partner nations: Japan United States Austria

In The Last Decade

Masayoshi Harigai

333 papers receiving 8.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Masayoshi Harigai

Since Specialization

Citations

This map shows the geographic impact of Masayoshi Harigai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayoshi Harigai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayoshi Harigai more than expected).

Fields of papers citing papers by Masayoshi Harigai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayoshi Harigai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayoshi Harigai. The network helps show where Masayoshi Harigai may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Masayoshi Harigai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masayoshi Harigai Line = papers co-authored together Masayoshi Harigai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mortality and risk factors in Japanese patients with rheumatoid arthritis: a 14-year observation of the IORRA cohort Modern Rheumatology ·Naohiro Sugitani,Eiichi Tanaka,Eisuke Inoue,Eri Sugano,Moeko Ochiai,Katsunori Ikari,Ayako Nakajima,Hisashi Yamanaka,Masayoshi Harigai	2025	1
2	2024 Update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis: Secondary publication Modern Rheumatology ·Masayoshi Harigai,Yuko Kaneko,Eiichi Tanaka,Shintaro Hirata,Hideto Kameda,Kayoko Kaneko,Mitsumasa Kishimoto,Masataka Kohno,Masayo Kojima,Toshihisa Kojima,Akio Morinobu,Ayako Nakajima,Takahiko Sugihara,Mie Fusama,Nobuyuki Yajima,Ryo Yanai,Yutaka Kawahito	2025	4
3	Nationwide epidemiological survey of polyarteritis nodosa in Japan in 2020 Modern Rheumatology ·Mai Kawazoe,Toshihiro Nanki,Keigo Saeki,Hideki Ishikawa,Yoshikazu Nakamura,Soko Kawashima,Shuichi Ito,Masanari Kodera,Naoko Konda,Shinya Kaname,Masayoshi Harigai	2024	2
4	Higher risk of poor functional outcome and unfavourable clinical events for late-onset rheumatoid arthritis: results from the IORRA cohort Lara D. Veeken ·Naohiro Sugitani,Eiichi Tanaka,Eisuke Inoue,Mai Abe,Eri Sugano,Kumiko Saka,Moeko Ochiai,Rei Yamaguchi,Katsunori Ikari,Hisashi Yamanaka,Masayoshi Harigai	2024	2
5	AB0219 LONG-TERM OUTCOMES OF METHOTREXATE IN ELDERLY-ONSET RA IMPLEMENTING THE TREAT-TO-TARGET STRATEGY Annals of the Rheumatic Diseases ·H. Baba,Takahiko Sugihara,Tatsuro Ishizaki,M. Nomura,Tadashi Hosoya,Mari Kamiya,T. Matsumoto,K. Kubo,Fumio Hirano,N. Miyasaka,Masayo Kojima,Shinsuke Yasuda,Masayoshi Harigai	2023	1
6	AB0286 RETENTION RATE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH DECREASED KIDNEY FUNCTION: RESULTS FROM THE IORRA COHORT Annals of the Rheumatic Diseases ·Tomoyuki Higuchi,Eiichi Tanaka,Eisuke Inoue,Mai Abe,K. Saka,Eri Sugano,Naohiro Sugitani,H. Yoko,Moeko Ochiai,Rei Yamaguchi,Katsunori Ikari,Yamanaka Hisashi,Masayoshi Harigai	2023	1
7	Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort Modern Rheumatology ·Naohiro Sugitani,Eiichi Tanaka,Eisuke Inoue,Mai Abe,Eri Sugano,Kumiko Saka,Moeko Ochiai,Yoko Higuchi,Rei Yamaguchi,Naoki Sugimoto,Katsunori Ikari,Ayako Nakajima,Hisashi Yamanaka,Masayoshi Harigai	2023	1
8	Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study Clinical Rheumatology ·Masanori Nakayama,Takefumi Furuya,Eisuke Inoue,Eiichi Tanaka,Katsunori Ikari,Hisashi Yamanaka,Masayoshi Harigai	2023	9
9	Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort Lara D. Veeken ·Eri Sugano,Eiichi Tanaka,Eisuke Inoue,Suguru Honda,Mai Abe,Kumiko Saka,Naohiro Sugitani,Moeko Ochiai,Rei Yamaguchi,Katsunori Ikari,Masayoshi Harigai	2023	3
10	Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance Modern Rheumatology ·Masataka Kuwana,Naonobu Sugiyama,Shigeki Momohara,Tatsuya Atsumi,Syuji Takei,Naoto Tamura,Masayoshi Harigai,Takao Fujii,Hiroaki Matsuno,Tsutomu Takeuchi,Kazuhiko Yamamoto,Yoshinari Takasaki,Miki Tanigawa,Yutaka Endo,Tomohiro Hirose,Yosuke Morishima,Noritoshi Yoshii,Tsuneyo Mimori,Michiaki Takagi	2023	6
11	Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data PLoS ONE ·Eiichi Tanaka,Eisuke Inoue,Ayako Shoji,Jonas Nilsson,C. Papagiannopoulos,Devender Dhanda,Yuri Yoshizawa,Mai Abe,Kumiko Saka,Eri Sugano,Naohiro Sugitani,Moeko Ochiai,Rei Yamaguchi,Katsunori Ikari,Hisashi Yamanaka,Masayoshi Harigai	2022	3
12	Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: A retrospective analysis using the IORRA database Modern Rheumatology ·Ryoko Sakai,Eiichi Tanaka,Eisuke Inoue,Minako Sato,Masaru Tanaka,Katsunori Ikari,Hisashi Yamanaka,Masayoshi Harigai	2022	4
13	Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication Modern Rheumatology ·Yutaka Kawahito,Akio Morinobu,Yuko Kaneko,Masataka Kohno,Shintaro Hirata,Mitsumasa Kishimoto,Yohei Seto,Takahiko Sugihara,Eiichi Tanaka,Hiromu Ito,Toshihisa Kojima,Isao Matsushita,Keiichiro Nishida,Masaaki Mori,Atsuko Murashima,Hisashi Yamanaka,Takeo Nakayama,Masayo Kojima,Masayoshi Harigai	2022	57
14	Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis Rheumatology Advances in Practice ·Wataru Hirose,Masayoshi Harigai,Koichi Amano,Toshihiko Hidaka,Kenji Itoh,Kazutoshi Aoki,Masahiro Nakashima,Hayato Nagasawa,Yukiko Komano,Toshihiro Nanki	2022	4
15	Patients’ perspectives of rheumatoid arthritis treatment: a questionnaire survey for the 2020 update of the Japan college of rheumatology clinical practice guidelines Modern Rheumatology ·Masayo Kojima,Mieko Hasegawa,Shintaro Hirata,Hiromu Ito,Yuko Kaneko,Mitsumasa Kishimoto,Masataka Kohno,Toshihisa Kojima,Isao Matsushita,Masaaki Mori,Akio Morinobu,Atsuko Murashima,Keiichiro Nishida,Yohei Seto,Yasumori Sobue,Takahiko Sugihara,Eiichi Tanaka,Takeo Nakayama,Yutaka Kawahito,Masayoshi Harigai	2021	5
16	Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis Modern Rheumatology ·Takahiko Sugihara,Yutaka Kawahito,Akio Morinobu,Yuko Kaneko,Yohei Seto,Toshihisa Kojima,Hiromu Ito,Masataka Kohno,Takeo Nakayama,Yasumori Sobue,Keiichiro Nishida,Isao Matsushita,Atsuko Murashima,Masaaki Mori,Eiichi Tanaka,Shintaro Hirata,Mitsumasa Kishimoto,Hisashi Yamanaka,Masayo Kojima,Masayoshi Harigai	2021	11
17	Patient satisfaction with total joint replacement surgery for rheumatoid arthritis: a questionnaire survey for the 2020 update of the Japan college of rheumatology clinical practice guidelines Modern Rheumatology ·Yasumori Sobue,Masayo Kojima,Toshihisa Kojima,Hiromu Ito,Keiichiro Nishida,Isao Matsushita,Shintaro Hirata,Yuko Kaneko,Mitsumasa Kishimoto,Masataka Kohno,Atsuko Murashima,Akio Morinobu,Masaaki Mori,Takeo Nakayama,Takahiko Sugihara,Yohei Seto,Eiichi Tanaka,Mieko Hasegawa,Yutaka Kawahito,Masayoshi Harigai	2021	2
18	Association Between Reappearance of Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Arthritis & Rheumatology ·Haruki Watanabe,Ken‐ei Sada,Yoshinori Matsumoto,Masayoshi Harigai,Koichi Amano,Hiroaki Dobashi,Shouichi Fujimoto,Joichi Usui,Kunihiro Yamagata,Tatsuya Atsumi,Shogo Banno,Takahiko Sugihara,Yoshihiro Arimura,Seiichi Matsuo,Hirofumi Makino	2018	28
19	Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T) Modern Rheumatology ·Yoshiya Tanaka,Tsutomu Takeuchi,Masayoshi Harigai,Hisashi Yamanaka,Toshikazu Nakano,Koshiro Akagi,Yoshifumi Ukyo,Benjamin Hsu	2018	3
20	A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis Modern Rheumatology ·S Kobayashi,Masayoshi Harigai,Neelufar Mozaffarian,Aileen L. Pangan,Shringi Sharma,L Brown,Nobuyuki Miyasaka	2012	12

About Masayoshi Harigai

Masayoshi Harigai is a scholar working on Rheumatology, Genetics and Hematology, having authored 345 papers that have together received 8.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (138 papers), Systemic Lupus Erythematosus Research (88 papers), Chronic Lymphocytic Leukemia Research (70 papers), Vasculitis and related conditions (60 papers), Lymphoma Diagnosis and Treatment (45 papers), Autoimmune and Inflammatory Disorders Research (40 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (27 papers) and Systemic Sclerosis and Related Diseases (23 papers). The work is most often cited by research in Rheumatology (3.7k citations), Hematology (1.2k citations) and Genetics (1.1k citations). Masayoshi Harigai has collaborated with scholars based in Japan, United States and Austria. Frequent co-authors include John C. Reed, Hisashi Yamanaka, Masahito Hanada, Masako Hara, Tsutomu Takeuchi, Toshiyuki Miyashita, Yoshiya Tanaka, Nobuyuki Miyasaka, Yasushi Kawaguchi and Naoki Ishiguro. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact